Global Harmonization of Device Regulations

Abstract

A medical device approved in the European Union faces a distinct and largely parallel regulatory process in the United States, Canada, Australia, Japan, and each additional market where the manufacturer wishes to sell. The clinical evidence generated for EU MDR approval may be accepted, partially accepted, or entirely replicated depending on the jurisdiction and the available bilateral arrangements. The aggregate cost of this regulatory fragmentation is borne by manufacturers through duplicated submissions, delayed market access, and regulatory affairs headcount that grows with every new market entered. It is ultimately borne by patients through delayed access to approved devices and by healthcare systems through the overhead costs that regulatory inefficiency generates. This study presents the Global Device Regulation Harmonization Assessment Framework (GDRHAF), evaluating five harmonization mechanisms - IMDRF technical document adoption (IMDRF-TDA), bilateral mutual recognition agreements (MRA-B), regulatory reliance pathways (REL-P), guideline convergence programmes (GCP-H), and AI-assisted comparative regulatory analysis (AI-CRA) -- across four device regulatory contexts: high-risk active implantable devices, in vitro diagnostic devices, software as a medical device, and general-purpose non-implantable devices. Performance was scored using the Harmonization Effectiveness Score (HES), a weighted composite of regulatory burden reduction (0.30), market access speed improvement (0.20), safety equivalence maintenance (0.20), implementation feasibility (0.15), and industry adoption rate (0.15). Regulatory reliance pathways achieved the highest HES (0.889), combining the best regulatory burden reduction (0.920) with strong market access improvement (0.900). Guideline convergence programmes ranked second (0.879) with the highest implementation feasibility (0.920) and industry adoption (0.900), reflecting their lower implementation threshold relative to bilateral agreements. IMDRF technical document adoption scored 0.877 with the best safety equivalence maintenance (0.920). AI-assisted regulatory analysis scored lowest (0.851) as a supporting rather than primary harmonization mechanism.